| 摘要 |
The invention relates to a cineole-containing dosage form for peroral application in the form of a capsule-in-capsule system, where the capsule-in-capsule system has an outer capsule (outside capsule) having an outer capsule shell and a plurality of inner capsules (inside capsules) located in the outer capsule, where the inner capsules are completely enclosed by the capsule shell of the outer capsule and are designed as microcapsules which contain the active ingredient 1,8-cineole together with at least one liquid physiologically safe carrier which is miscible with 1,8-cineole at 20°C and atmospheric pressure, where the carrier is selected from the group of triglycerides, wherein the carrier is used in a 1,8-cineole/carrier quantitative ratio in the range from 5:1 to 1:2. The invention further relates to the production process and use of the dosage form containing cineole. |
